Dr. Jawdat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Rainbow Blvd
# 3599
Kansas City, KS 66160Phone+1 913-588-6970Fax+1 913-588-0673
Summary
- http://www.kumc.edu/school-of-medicine/neurology/faculty/omar-jawdat-md.html
Education & Training
University of Kansas School of MedicineFellowship, Neuromuscular Medicine (Neurology), 2013 - 2014- University of Kansas School of MedicineChief Residency, Neurology, 2012 - 2013
- University of Kansas School of MedicineResidency, Neurology, 2009 - 2013
University of Baghdad College of MedicineClass of 2002
Certifications & Licensure
MO State Medical License 2021 - 2026
KS State Medical License 2012 - 2025
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Trial of Oxaloacetate in ALS Start of enrollment: 2020 Mar 17
Publications & Presentations
PubMed
- Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.Sabrina Paganoni, Christina N Fournier, Eric A Macklin, Lori B Chibnik, Melanie Quintana
JAMA Network Open. 2025-02-03 - A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.Salman Bhai, Todd Levine, Dan Moore, Robert Bowser, Andrew J Heim
Muscle & Nerve. 2025-01-01 - Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial.Steven Perrin, Shafeeq Ladha, Nicholas Maragakis, Michael H Rivner, Jonathan Katz
Plos Medicine. 2024-10-01
Journal Articles
- Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)Richard J Barohn, Mamatha Pasnoor, Omar Jawdat, Mazen M Dimachkie, JAMA Neurology
- Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials.van den Berg LH1, Sorenson E2, Gronseth G2, Macklin EA2, Andrews J2, Baloh RH2, Benatar M2, Berry JD2, Chio A2, Corcia P2, Genge A2, Gubitz AK2, Lomen-Hoerth C2, McDer..., Neurology, 4/2019
Authored Content
- Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)August 2020
- Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)August 2020
Press Mentions
KC Man Diagnosed with ALS Will Be Part of Highly Competitive Medical TrialApril 26th, 2021
External Links
- University Biohttp://www.kumc.edu/school-of-medicine/neurology/faculty/omar-jawdat-md.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
